NovoCure Limited (NASDAQ:NVCR) Q4 2025 Earnings Call Transcript February 26, 2026
NovoCure Limited beats earnings expectations. Reported EPS is $-0.21978, expectations were $-0.41.
Operator: Good day, and thank you for standing by. Welcome to the NovoCure Fourth Quarter 2025 Earnings Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I’d now like to hand the conference over to Adam Daney, Head of Investor Relations. Please go ahead.
Adam Daney: Good...
